NEW YORK (GenomeWeb) – Signal Genetics reported on Wednesday a 43 percent drop in its second quarter revenues on a sharp decrease in test orders. 

The Carlsbad, California-based molecular diagnostics firm said that for the three months ended June 30, it recorded $734,000 in revenues, down from $1.3 million in the year-ago quarter. Test orders retreated 24 percent year over year to 770 in Q2 2015, resulting from a decrease in the number of tests billed for research and clinical patients at the University of Arkansas Medical Sciences, Signal's primary customer. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.